Puretech Health (PTCHF) Stock Price, News & Analysis
Company Description
PTCHF has declined 13.6% over the past year. Shares last traded at $1.53.
For FY2024, Puretech Health reported revenue of $4.8M with net income of $27.8M. The company operates at a net profit margin of 575.4%.
This page collects what Stock Titan holds for PTCHF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Puretech Health (PTCHF) last closed at $1.53. Over the past 12 months, PTCHF has lost 13.6%.
PTCHF Rankings
Latest News
SEC Filings
Puretech Health has filed 5 recent SEC filings, including 1 Form 25, 1 Form SCHEDULE 13G/A, 1 Form SCHEDULE 13G, 1 Form 20-F. The most recent filing was submitted on May 11, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all PTCHF SEC filings →
Financial Highlights
Puretech Health generated $4.8M in revenue in FY2024, and net income was $27.8M, reflecting a 575.4% net profit margin. The company generated -$134.4M in operating cash flow. With a current ratio of 9.33, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Puretech Health (PTCHF) currently stands at 52.7 thousand shares, up 16.3% from the previous reporting period, representing 0.0% of the float. Since July 2025, short interest has decreased by 53.1%. This relatively low short interest suggests limited bearish sentiment. The 6.2 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Puretech Health (PTCHF) currently stands at 6.2 days, down 99.4% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has decreased 80.6% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.